Intranasal sufentanil/ketamine analgesia in children

Paediatric Anaesthesia

Volumn 24, Issue 2, 2014, Pages 170-180

  Nielsen, Bettina N ^a   Friis, Susanne M ^b   Rømsing, Janne ^a   Schmiegelow, Kjeld ^a,b   Anderson, Brian J ^c   Ferreirõs, Nerea ^d   Labocha, Sandra ^d   Henneberg, Steen W ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b University of Copenhagen   (Denmark)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

analgesia; children; intranasal administration; ketamine; pharmacokinetics; sufentanil

Indexed keywords

KETAMINE; SUFENTANIL; ANESTHETIC AGENT; NARCOTIC ANALGESIC AGENT;

ANALGESIA; ARTICLE; BODY WEIGHT; CENTRAL VENOUS CATHETER; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG FORMULATION; FEMALE; HEART RATE; HUMAN; MALE; OXYGEN SATURATION; PAIN; PAIN ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROCEDURAL PAIN; RATING SCALE; SCHOOL CHILD; SEDATION; TASTE DISORDER; VOMITING; ADOLESCENT; CLINICAL TRIAL; COMPUTER SIMULATION; DRUG EFFECTS; INFANT; INTRANASAL DRUG ADMINISTRATION; PAIN MEASUREMENT; PATIENT MONITORING; PROSPECTIVE STUDY;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ANALGESICS, OPIOID; ANESTHETICS, DISSOCIATIVE; CHILD; CHILD, PRESCHOOL; COMPUTER SIMULATION; FEMALE; HUMANS; INFANT; KETAMINE; MALE; MONITORING, INTRAOPERATIVE; PAIN MEASUREMENT; PROSPECTIVE STUDIES; SUFENTANIL;

EID: 84891825530     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/pan.12268     Document Type: Article

References (50)

1. Blount RL, Piira T, Cohen LL, et al,. Pediatric procedural pain. Behav Modif 2006; 30: 24-49.
2. Hadley G, Maconochie I, Jackson A,. A survey of intranasal medication use in the paediatric emergency setting in England and Wales. Emerg Med J 2010; 27: 553-554.
3. Kendall JM, Reeves BC, Latter VS,. Multicentre randomised controlled trial of nasal diamorphine for analgesia in children and teenagers with clinical fractures. BMJ 2001; 322: 261-265.
4. Rey E, Delaunay L, Pons G, et al,. Pharmacokinetics of midazolam in children: comparative study of intranasal and intravenous administration. Eur J Clin Pharmacol 1991; 41: 355-357.
5. Henderson JM, Brodsky DA, Fisher DM, et al,. Pre-induction of anesthesia in pediatric patients with nasally administered sufentanil. Anesthesiology 1988; 68: 671-675.
6. Karl HW, Keifer AT, Rosenberger JL, et al,. Comparison of the safety and efficacy of intranasal midazolam or sufentanil for preinduction of anesthesia in pediatric patients. Anesthesiology 1992; 76: 209-215.
7. Abrams R, Morrison JE, Villasenor A, et al,. Safety and effectiveness of intranasal administration of sedative medications (ketamine, midazolam, or sufentanil) for urgent brief pediatric dental procedures. Anesth Prog 1993; 40: 63-66.
8. Zedie N, Amory DW, Wagner BK, et al,. Comparison of intranasal midazolam and sufentanil premedication in pediatric outpatients. Clin Pharmacol Ther 1996; 59: 341-348.
9. Weber F, Wulf H, el Saeidi G,. Premedication with nasal s-ketamine and midazolam provides good conditions for induction of anesthesia in preschool children. Can J Anaesth 2003; 50: 470-475.
10. Weksler N, Ovadia L, Muati G, et al,. Nasal ketamine for paediatric premedication. Can J Anaesth 1993; 40: 119-121.
11. Diaz JH,. Intranasal ketamine preinduction of paediatric outpatients. Paediatr Anaesth 1997; 7: 273-278.
12. Roelofse JA, Shipton EA, de la Harpe CJ, et al,. Intranasal sufentanil/midazolam versus ketamine/midazolam for analgesia/sedation in the pediatric population prior to undergoing multiple dental extractions under general anesthesia: a prospective, double-blind, randomized comparison. Anesth Prog 2004; 51: 114-121.
13. Drover DR, Hammer GB, Anderson BJ,. The pharmacokinetics of ketorolac after single postoperative intranasal administration in adolescent patients. Anesth Analg 2012; 114: 1270-1276.
14. Borland M, Jacobs I, King B, et al,. A randomized controlled trial comparing intranasal fentanyl to intravenous morphine for managing acute pain in children in the emergency department. Ann Emerg Med 2007; 49: 335-340.
15. Lundeberg S, Roelofse JA,. Aspects of pharmacokinetics and pharmacodynamics of sufentanil in pediatric practice. Pediatr Anesth 2011; 21: 274-279.
16. Malviya S, Voepel-Lewis T, Tait AR, et al,. Depth of sedation in children undergoing computed tomography: validity and reliability of the University of Michigan Sedation Scale (UMSS). Br J Anaesth 2002; 88: 241-245.
17. Haynes G, Brahen NH, Hill HF,. Plasma sufentanil concentration after intranasal administration to paediatric outpatients. Can J Anaesth 1993; 40: 286.
18. Helmers JH, Noorduin H, Van Peer A, et al,. Comparison of intravenous and intranasal sufentanil absorption and sedation. Can J Anaesth 1989; 36: 494-497.
19. Steenblik J, Goodman M, Davis V, et al,. Intranasal sufentanil for the treatment of acute pain in a winter resort clinic. Am J Emerg Med 2012; 30: 1817-1821.
20. Merkel SI, Voepel-Lewis T, Shayevitz JR, et al,. The FLACC: a behavioral scale for scoring postoperative pain in young children. Pediatr Nurs 1997; 23: 293-297.
21. McGrath PJ, Walco GA, Turk DC, et al,. Core outcome domains and measures for pediatric acute and chronic/recurrent pain clinical trials: PedIMMPACT recommendations. J Pain 2008; 9: 771-783.
22. Wong DL, Baker CM,. Pain in children: comparison of assessment scales. Pediatr Nurs 1988; 14: 9-17.
23. Huguet A, Stinson JN, McGrath PJ,. Measurement of self-reported pain intensity in children and adolescents. J Psychosom Res 2010; 68: 329-336.
24. Schmidt R, Bremerich DH, Geisslinger G,. High sensitive determination of sufentanil in human plasma of parturients and neonates following patient-controlled epidural analgesia (PCEA). J Chromatogr B Analyt Technol Biomed Life Sci 2006; 836: 98-107.
25. Geisslinger G, Menzel-Soglowek S, Kamp HD, et al,. Stereoselective high-performance liquid chromatographic determination of the enantiomers of ketamine and norketamine in plasma. J Chromatogr 1991; 568: 165-176.
26. Herd DW, Anderson BJ, Holford NH,. Modeling the norketamine metabolite in children and the implications for analgesia. Pediatr Anesth 2007; 17: 831-840.
27. Gepts E, Shafer SL, Camu F, et al,. Linearity of pharmacokinetics and model estimation of sufentanil. Anesthesiology 1995; 83: 1194-1204.
28. Costantino HR, Illum L, Brandt G, et al,. Intranasal delivery: physicochemical and therapeutic aspects. Int J Pharm 2007; 337: 1-24.
29. Malinovsky JM, Servin F, Cozian A, et al,. Ketamine and norketamine plasma concentrations after i.v., nasal and rectal administration in children. Br J Anaesth 1996; 77: 203-207.
30. Weber F, Wulf H, Gruber M, et al,. S-ketamine and s-norketamine plasma concentrations after nasal and i.v. administration in anesthetized children. Pediatr Anesth 2004; 14: 983-988.
31. Mathieu N, Cnudde N, Engelman E, et al,. Intranasal sufentanil is effective for postoperative analgesia in adults. Can J Anaesth 2006; 53: 60-66.
32. Malinovsky JM, Servin F, Cozian A, et al,. Ketamine and norketamine plasma concentrations after i.v., nasal and rectal administration in children. Br J Anaesth 1996; 77: 203-207.
33. Grant IS, Nimmo WS, McNicol LR, et al,. Ketamine disposition in children and adults. Br J Anaesth 1983; 55: 1107-1111.
34. Bovill JG, Sebel PS, Blackburn CL, et al,. The pharmacokinetics of sufentanil in surgical patients. Anesthesiology 1984; 61: 502-506.
35. Davis PJ, Stiller RL, Cook DR, et al,. Pharmacokinetics of sufentanil in adolescent patients with chronic renal failure. Anesth Analg 1988; 67: 268-271.
36. Greeley WJ, de Bruijn NP, Davis DP,. Sufentanil pharmacokinetics in pediatric cardiovascular patients. Anesth Analg 1987; 66: 1067-1072.
37. Anderson BJ, Holford NH,. Mechanism-based concepts of size and maturity in pharmacokinetics. Annu Rev Pharmacol Toxicol 2008; 48: 303-332.
38. Yanagihara Y, Ohtani M, Kariya S, et al,. Plasma concentration profiles of ketamine and norketamine after administration of various ketamine preparations to healthy Japanese volunteers. Biopharm Drug Dispos 2003; 24: 37-43.
39. Herd DW, Anderson BJ, Keene NA, et al,. Investigating the pharmacodynamics of ketamine in children. Pediatr Anesth 2008; 18: 36-42.
40. Scott JC, Cooke JE, Stanski DR,. Electroencephalographic quantitation of opioid effect: comparative pharmacodynamics of fentanyl and sufentanil. Anesthesiology 1991; 74: 34-42.
41. Grant IS, Nimmo WS, Clements JA,. Pharmacokinetics and analgesic effects of i.m. and oral ketamine. Br J Anaesth 1981; 53: 805-810.
42. Clements JA, Nimmo WS,. Pharmacokinetics and analgesic effect of ketamine in man. Br J Anaesth 1981; 53: 27-30.
43. Lehmann KA, Gerhard A, Horrichs-Haermeyer G, et al,. Postoperative patient-controlled analgesia with sufentanil: analgesic efficacy and minimum effective concentrations. Acta Anaesthesiol Scand 1991; 35: 221-226.
44. Bruce E, Franck L, Howard RF,. The efficacy of morphine and Entonox analgesia during chest drain removal in children. Pediatr Anesth 2006; 16: 302-308.
45. Anderson B, Cranswick N,. The placebo (I shall please) - is it so pleasing in children?. Pediatr Anesth 2005; 15: 809-813.
46. Efron B,. Bootstrap methods: another look at the jackknife. Ann Stat 1979; 7: 1-26.
47. Post TM, Freijer JI, Ploeger BA, et al,. Extensions to the visual predictive check to facilitate model performance evaluation. J Pharmacokinet Pharmacodyn 2008; 35: 185-202.
48. Karlsson MO, Savic RM,. Diagnosing model diagnostics. Clin Pharmacol Ther 2007; 82: 17-20.
49. Standing JF, Hammer GB, Sam WJ, et al,. Pharmacokinetic-pharmacodynamic modeling of the hypotensive effect of remifentanil in infants undergoing cranioplasty. Pediatr Anesth 2011; 20: 7-18.
50. Gisleskog PO, Karlsson MO, Beal SL,. Use of prior information to stabilize a population data analysis. J Pharmacokinet Pharmacodyn 2002; 29: 473-505.